| Page | Response |
|---|---|
| Why we are consulting | This page has no questions |
| Consultation details | This page has no questions |
| How to respond | This page has no questions |
| Confidentiality and data protection | This page has no questions |
| About you |
0 percent complete
0 of 5 questions answered
|
| Introduction | This page has no questions |
| Option 1 – Medicines must be imported into a ManA site and be certified by a QP |
0 percent complete
0 of 3 questions answered
|
| Option 2 – No additional requirements for medicines batch tested and released in exempt countries |
0 percent complete
0 of 3 questions answered
|
| Option 3 – The introduction of a market access scheme for wholesale dealers |
0 percent complete
0 of 3 questions answered
|
| Additional points to consider - risk-based audits |
0 percent complete
0 of 2 questions answered
|
| Additional points to consider - additions to the CERS list |
0 percent complete
0 of 2 questions answered
|